HIGHLIGHTS
- who: Qianmei Hu and colleagues from the The Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, and Department of Pharmacy, School of Medicine, Hunan Normal University, Changsha, China have published the research work: Neuroprotective Effects of the Psychoactive Compound Biatractylolide (BD) in Alzheimeru2019s Disease, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: This study provides a theoretical basis for the development of BD as an anti-Alzheimer`s disease drug. the Psychoactive Compound Biatractylolide (BD) in Alzheimer`s Disease. The authors developed a systems pharmacology . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.